RECURRENT OLIGODENDROGLIOMA
Clinical trials for RECURRENT OLIGODENDROGLIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT OLIGODENDROGLIOMA trials appear
Sign up with your email to follow new studies for RECURRENT OLIGODENDROGLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cell therapy trial hopes to tackle recurrent brain cancer
Disease control Recruiting nowThis early-stage trial is testing a personalized cell therapy for adults with recurrent oligodendroglioma, a type of brain tumor. The treatment involves taking a patient's own immune cells and stem cells, modifying them in the lab, and giving them back to fight the tumor. The mai…
Matched conditions: RECURRENT OLIGODENDROGLIOMA
Phase: PHASE1 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can this drug cross the Brain's barrier to fight tumors?
Knowledge-focused Recruiting nowThis early-stage trial is testing whether the drug ulixertinib can cross the blood-brain barrier in people with recurrent brain tumors called gliomas. About 40 adults will take the drug before surgery to see how much reaches the tumor and how safe it is. The goal is to learn if t…
Matched conditions: RECURRENT OLIGODENDROGLIOMA
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC